Success Metrics

Active Trials
2(67%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(3)

Detailed Status

Not yet recruiting1
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
N/A

Trials by Status

not_yet_recruiting133%
recruiting133%
active_not_recruiting133%

Recent Activity

2 active trials
Showing 3 of 3
active_not_recruiting

Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients

NCT05415358
recruiting

Pan-tumor MRD Study

NCT06605404
not_yet_recruiting

Impact of VARIation of OXYdo-reduction Potential in Cardiac Surgery on Post-operative Outcome

NCT06840327

Clinical Trials (3)

Showing 3 of 3 trials
NCT05415358

Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients

Active Not Recruiting
NCT06605404

Pan-tumor MRD Study

Recruiting
NCT06840327

Impact of VARIation of OXYdo-reduction Potential in Cardiac Surgery on Post-operative Outcome

Not Yet Recruiting

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3